Oculis Holding Ag (OCS)

$11.52

-0.01

(-0.04%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $11.52
    $11.52
    $11.52
    downward going graph

    0.0%

    Downside

    Day's Volatility :0.0%

    Upside

    0.0%

    downward going graph
  • $9.05
    $14.50
    $11.52
    downward going graph

    21.44%

    Downside

    52 Weeks Volatility :37.59%

    Upside

    20.55%

    downward going graph

Returns

PeriodOculis Holding AgIndex (Russel 2000)
3 Months
-3.8%
0.0%
6 Months
-3.39%
0.0%
1 Year
-4.83%
0.0%
3 Years
5.83%
-19.9%

Highlights

Market Capitalization
550.4M
Book Value
$2.15
Earnings Per Share (EPS)
0.18
PE Ratio
65.83
Wall Street Target Price
28.46
Profit Margin
0.0%
Operating Margin TTM
-6904.51%
Return On Assets TTM
-37.85%
Return On Equity TTM
-1025.63%
Revenue TTM
876.0K
Revenue Per Share TTM
0.02
Quarterly Revenue Growth YOY
-3.1%
Gross Profit TTM
-21.3M
EBITDA
-51.1M
Diluted Eps TTM
0.18
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.92
EPS Estimate Next Year
-2.4
EPS Estimate Current Quarter
-0.41
EPS Estimate Next Quarter
-0.43

Analyst Recommendation

Buy
    92%Buy
    7%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Oculis Holding Ag(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 147.05%

Current $11.52
Target $28.46

Technicals Summary

Sell

Neutral

Buy

Oculis Holding Ag is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Oculis Holding Ag
Oculis Holding Ag
-2.82%
-3.39%
-4.83%
5.83%
5.83%
Moderna, Inc.
Moderna, Inc.
-11.5%
19.92%
-1.43%
-63.9%
737.94%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.78%
11.32%
45.17%
82.69%
236.57%
Novo Nordisk A/s
Novo Nordisk A/s
-6.33%
26.68%
64.47%
198.6%
438.18%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.24%
14.68%
37.33%
146.48%
182.87%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Oculis Holding Ag
Oculis Holding Ag
65.83
65.83
NA
-1.92
-10.26
-0.38
NA
2.15
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.55
31.55
1.46
44.35
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.95
45.95
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.16
32.16
0.53
17.04
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Oculis Holding Ag
Oculis Holding Ag
Buy
$550.4M
5.83%
65.83
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.9B
737.94%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.9B
236.57%
31.55
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$591.6B
438.18%
45.95
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$128.0B
182.87%
32.16
39.46%

Insights on Oculis Holding Ag

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 185.0K → 222.0K (in $), with an average increase of 16.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -12.49M → -16.09M (in $), with an average decrease of 28.8% per quarter

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 64.5% return, outperforming this stock by 69.3%

Company Information

Organization
Oculis Holding Ag
Employees
36
CEO
Dr. Riad Sherif M.B.A., M.D.
Industry
Miscellaneous

FAQs